NAPA, California, March 31 /PRNewswire/ --
- Media Attention Builds for Pyratine-6(TM) and Pyratine XR(TM)
Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the development of technologies that target the science of healthy aging, announced results for the fourth quarter and year ended December 31, 2008.
Revenue for the year ended December 31, 2008 was US$1,845,000, compared with US$26,471,000 reported in 2007. Revenues for the fourth quarter of 2008 were US$230,000, compared with US$223,000 for the same period in the prior year.